- Stocks
- Pharma & Healthcare
- Fischer Medical Ventures
Fischer Medical Ventures share price
NSE: FISCHERPharma & HealthcareMedical Devices
Fischer Medical Ventures at a glance
Fischer Medical Ventures (NSE: FISCHER) closed at ₹26.28 on 21 Oct 2026, down 6.84% on the day. With a market capitalisation of ₹1,720 Cr, it ranks 1207th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Devices.
At its last close the stock traded at 58.4× trailing earnings, against a return on equity of 0.4% in FY25. Over the past year the share price has fallen 73.2%. Its 52-week range is ₹26.05 (21 Oct 2026) to ₹121.70 (29 Oct 2025); the last close is 78.4% below the high. Promoters held 62.15% of the company as of 30 Jun 2026; 7.38% of promoter shares were pledged.
Key numbers
- Market cap
- ₹1,720 CrRank 1207 on NSE
- P/E (trailing)
- 58.4×
- Price to book
- 16.97×FY25
- ROE
- 0.4%FY25
- ROCE
- 0.9%FY25
- Debt to equity
- 0.18FY25
- Net profit margin
- 1.5%FY25
- Book value / share
- ₹52.90FY25
- 52-week high
- ₹121.7029 Oct 2025
- 52-week low
- ₹26.0521 Oct 2026
- 1-year return
- −73.2%
- RSI (14-day)
- 17.5
Returns to 21 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −6.84% | −12.6% | −21.3% | −34.1% | −73.2% |
Fischer Medical Ventures financials
| Item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | ₹0 Cr | ₹21 Cr | ₹111 Cr |
| Operating profit | ₹0 Cr | ₹2 Cr | ₹3 Cr |
| Net profit | −₹0 Cr | ₹2 Cr | ₹2 Cr |
| EPS (₹) | −₹2.00 | ₹2.00 | ₹0.00 |
| Cash from operations | ₹0 Cr | −₹8 Cr | −₹87 Cr |
| Total debt | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | −₹0 Cr | ₹81 Cr | ₹338 Cr |
Fischer Medical Ventures shareholding pattern
| Holder | 30 Jun 2025 | 13 Sep 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 61.80% | 61.80% | 61.80% | 61.80% | 62.15% | 62.15% |
| Foreign institutions | 5.55% | 5.61% | 5.57% | 4.85% | 4.97% | 5.48% |
| Domestic institutions | 1.42% | 1.42% | 1.42% | 1.36% | 1.38% | 1.35% |
| Non-institutions | 31.23% | 31.18% | 31.21% | 31.99% | 31.50% | 31.02% |
| Promoter shares pledged | — | — | — | — | 7.38% | 7.38% |
Fischer Medical Ventures vs peers
The listed Pharma & Healthcare companies nearest to Fischer Medical Ventures by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| HESTERBIOHester Biosciences | ₹2,230.60 | −2.17% | +31.9% | ₹1,898 Cr | 33 | — |
| BETABeta Drugs | ₹1,682.60 | −3.09% | −2.2% | ₹1,865 Cr | 41.2 | — |
| WINDLASWindlas Biotech | ₹896.70 | +0.50% | −1.6% | ₹1,850 Cr | 28.8 | — |
| TITANBIOTitan Biotech | — | — | — | ₹1,793 Cr | — | — |
| FISCHERFischer Medical Ventures | ₹26.28 | −6.84% | −73.2% | ₹1,720 Cr | 58.4 | — |
| NGLFINENGL Fine-Chem | ₹2,680.00 | −2.73% | +80.5% | ₹1,656 Cr | 34.4 | — |
| KRSNAAKrsnaa Diagnostics | ₹507.85 | −1.39% | −38.8% | ₹1,647 Cr | 16.4 | — |
Ask anything about Fischer Medical Ventures
Pivot answers on the live chart with evidence you can check, and tests strategies against FISCHER's own history. Try: “Why has FISCHER moved over the last three months?” · “Backtest a 50-day moving-average crossover on FISCHER over five years” · “Compare FISCHER with HESTERBIO on margins and valuation”
Frequently asked questions about Fischer Medical Ventures
What is the share price of Fischer Medical Ventures today?
Fischer Medical Ventures (NSE: FISCHER) last closed at ₹26.28 on 21 Oct 2026. Its 52-week high is ₹121.70 and its 52-week low is ₹26.05.
What is the market cap of Fischer Medical Ventures?
Fischer Medical Ventures' market capitalisation is ₹1,720 Cr (₹1,720 Cr) at the 21 Oct 2026 close, ranking 1207th among the NSE companies Pivot tracks.
What is the P/E ratio of Fischer Medical Ventures?
Fischer Medical Ventures trades at a trailing P/E of 58.4. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 33.
What is the ROE and ROCE of Fischer Medical Ventures?
Return on equity was 0.4% in FY25 and return on capital employed was 0.9% in FY25 (consolidated figures).
Is Fischer Medical Ventures a debt-free company?
No. Fischer Medical Ventures' debt-to-equity ratio was 0.18 in FY25, with total debt of ₹0 Cr.
How has Fischer Medical Ventures stock performed over the last year?
Fischer Medical Ventures' share price has fallen 73.2% over the past year, −34.1% over three months and −21.3% over one month, to the 21 Oct 2026 close.
What is the shareholding pattern of Fischer Medical Ventures?
As of 30 Jun 2026: promoters 62.15%, foreign institutions 5.48%, domestic institutions 1.35%, non-institutions 31.02%. 7.38% of promoter shares were pledged.
Who are Fischer Medical Ventures' competitors?
The listed Pharma & Healthcare companies closest to Fischer Medical Ventures by market cap are Hester Biosciences, Beta Drugs, Windlas Biotech, Titan Biotech, NGL Fine-Chem and Krsnaa Diagnostics.
Is Fischer Medical Ventures a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Fischer Medical Ventures' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on FISCHER against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 21 Oct 2026 (returns and ratios at the 21 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with F · all NSE stocks · this page as text